Treatment strategies

Treatment interruptions may result in poor T-cell recovery in patients with nadir CD+ count <50 cells/mm3

13 November 2002. Related: Conference reports, Treatment strategies.

Treatment interruptions are safe in patients with CD4+ count between 300 to 500 cells/mm3 and viral loads lower than 70,000 copies/mL

13 November 2002. Related: Conference reports, Treatment strategies.

Treatment interruption strategy reports from the XIV International AIDS Conference

11 September 2002. Related: Conference reports, Treatment strategies.

Aminoperazine shows promise in enhancing immune response of HIV patients

1 October 2001. Related: Treatment strategies.

Interleukin-2 with dual nucleoside therapy

1 October 2001. Related: Treatment strategies.

Immunotherapy at the 1st IAS conference

1 September 2001. Related: Treatment strategies.

Outcome of patients with discordant responses to HAART

17 May 2001. Related: Antiretrovirals, Treatment strategies.

Preliminary data from four studies of double PI regimen using once daily Fortovase plus “mini dose” ritonavir

17 May 2001. Related: Antiretrovirals, Treatment strategies.

Interleukin-2 improves CD4+ cell counts in patients with poor immune response to HAART

17 April 2001. Related: Treatment strategies.

Use of cytokines in HIV: colony-stimulating factors, erythropoietin, and interleukin-2

17 April 2001. Related: Treatment strategies.

Structured treatment interruptions

17 December 2000. Related: Conference reports, Treatment strategies.

Study shows immune system can control HIV: early antiviral treatment primes the immune system to suppress viral levels without drugs

17 October 2000. Related: Treatment strategies, Basic science and immunology.

Human IL-12 may augment HIV-specific immunity in HIV-positive patients

17 October 2000. Related: Treatment strategies.

Structured treatment interruptions and treatment intensification

16 September 2000. Related: Treatment strategies.

New developments in affordable antiretroviral therapy: intermittent treatment

16 August 2000. Related: Conference reports, Treatment strategies.

Once-daily protease-based regimens

16 August 2000. Related: Conference reports, Antiretrovirals, Treatment strategies.

What is the significance of blips in viral load?

16 July 2000. Related: Conference reports, Treatment strategies.

Phase III study of GM-CSF in advanced HIV disease

15 June 2000. Related: Treatment strategies.

GM-CSF beneficial for patients with advanced HIV disease

15 May 2000. Related: Treatment strategies.

French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3

14 April 2000. Related: Treatment strategies.